Toxic deposits of the proteins amyloid beta and tau in the brain have been implicated in Alzheimer’s disease, but the understanding of exactly how these proteins interact to cause dementia is still largely a mystery. Scientists at the University of Washington are using stem cells from Alzheimer’s patients to study the two proteins—and they’ve hit upon a compound that seems to lessen the buildup of them in brain cells.
Continue reading...
No comments:
Post a Comment